Eun Ju Cho Selected Research

hachimijiogan (TJ 7)

12/2005	Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model.
10/2004	Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress.
1/2004	A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Ju Cho Research Topics

Disease

65	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 02/2012
31	Neoplasms (Cancer) 05/2024 - 02/2012
24	Body Weight (Weight, Body) 05/2020 - 09/2002
23	Inflammation (Inflammations) 03/2024 - 12/2005
21	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 03/2013
19	Chronic Hepatitis B 02/2024 - 03/2012
16	Cognitive Dysfunction 03/2023 - 03/2013
14	Fibrosis (Cirrhosis) 01/2023 - 12/2005
11	Hepatitis B 07/2023 - 01/2011
11	Infections 07/2022 - 01/2011
9	Hypertension (High Blood Pressure) 01/2022 - 11/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2023 - 05/2016
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 05/2014
6	Memory Disorders (Memory Loss) 03/2023 - 02/2010
6	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2015
5	Type 2 Diabetes Mellitus (MODY) 05/2024 - 09/2008
5	Liver Diseases (Liver Disease) 05/2024 - 12/2017
4	Diabetes Mellitus 05/2024 - 09/2002
4	Hemorrhage 10/2023 - 11/2017
4	Neuroinflammatory Diseases 03/2023 - 06/2018
4	Hepatitis 01/2023 - 01/2011
4	Liver Neoplasms (Liver Cancer) 01/2023 - 08/2016
4	Disease Progression 05/2022 - 11/2006
4	Obesity 01/2022 - 10/2019
4	Chronic Hepatitis C 01/2021 - 12/2015
4	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2011
4	Hyperlipidemias (Hyperlipidemia) 06/2020 - 07/2008
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2012
4	Hyperglycemia 11/2011 - 07/2008
3	Hypoxia (Hypoxemia) 09/2021 - 01/2016
3	End Stage Liver Disease 01/2021 - 05/2014
3	Proteinuria 01/2015 - 02/2004
3	Renal Insufficiency (Renal Failure) 11/2006 - 04/2003
3	Ischemia 02/2005 - 10/2002
2	Neuroblastoma 03/2024 - 04/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 06/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2023 - 06/2016
2	Carcinoma (Carcinomatosis) 01/2022 - 12/2016
2	Fatty Liver 01/2022 - 10/2012

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2004
17	Sorafenib (BAY 43-9006)FDA Link 10/2022 - 01/2017
15	Antiviral Agents (Antivirals)IBA 02/2024 - 05/2013
12	Amyloid beta-PeptidesIBA 06/2023 - 03/2013
11	Amyloid (Amyloid Fibrils)IBA 03/2024 - 07/2014
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2008
9	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 01/2013
9	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2002
8	Tenofovir (Viread)FDA Link 02/2024 - 11/2014
8	entecavir FDA Link 02/2024 - 05/2013
8	Fetal Proteins (Fetoprotein)IBA 05/2022 - 08/2013
8	CholesterolIBA 06/2020 - 01/2004
7	AntioxidantsIBA 03/2024 - 10/2002
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2023 - 06/2012
6	EnzymesIBA 01/2021 - 04/2003
6	Glycoproteins (Glycoprotein)IBA 12/2020 - 04/2003
5	LipopolysaccharidesIBA 03/2024 - 05/2003
5	Alanine Transaminase (SGPT)IBA 03/2022 - 12/2017
5	LipidsIBA 03/2021 - 01/2004
5	Kangen-karyuIBA 09/2007 - 07/2004
4	InterferonsIBA 03/2024 - 12/2015
4	Peptides (Polypeptides)IBA 03/2024 - 03/2020
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2023 - 06/2020
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2023 - 06/2020
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2022 - 01/2015
4	Hepatitis B e AntigensIBA 01/2022 - 01/2013
4	Streptozocin (Streptozotocin)FDA Link 11/2007 - 09/2002
3	Neuroprotective AgentsIBA 03/2024 - 12/2017
3	lenvatinibIBA 01/2024 - 03/2022
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 11/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 11/2018
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2022 - 01/2018
3	thiamine triphosphorate (TTP)IBA 03/2022 - 11/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020 - 07/2004
3	NF-kappa B (NF-kB)IBA 06/2020 - 09/2007
3	adefovirIBA 01/2020 - 05/2013
3	Serum AlbuminIBA 01/2020 - 01/2004
3	bromopyruvateIBA 03/2019 - 02/2012
3	HexokinaseIBA 03/2019 - 02/2012
3	oligonolIBA 01/2019 - 07/2014
3	Lamivudine (Epivir)FDA Link 02/2015 - 03/2012
3	Triglycerides (Triacylglycerol)IBA 01/2012 - 01/2004
3	FructoseIBA 05/2009 - 09/2007
3	hachimijiogan (TJ 7)IBA 12/2005 - 01/2004
3	Indicators and Reagents (Reagents)IBA 05/2003 - 09/2002
2	tenofovir alafenamideIBA 02/2024 - 01/2022
2	Rituximab (Mabthera)FDA Link 07/2023 - 06/2016
2	peoniflorinIBA 03/2023 - 12/2020
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2023 - 01/2023
2	Yttrium-90IBA 01/2023 - 01/2021
2	BilirubinIBA 03/2022 - 01/2017
2	ethyl acetateIBA 01/2022 - 05/2020

Therapy/Procedure

27	Therapeutics 01/2024 - 06/2009
10	Radiofrequency Ablation 05/2024 - 08/2013
10	Oral Administration 05/2018 - 09/2002
9	Liver Transplantation 03/2024 - 05/2016
5	Electrodes (Electrode) 05/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 07/2023 - 06/2016
3	Nephrectomy 11/2006 - 01/2004
2	Radiotherapy 01/2023 - 01/2021
2	Immunotherapy 01/2023 - 05/2019